NovaBay Pharmaceuticals Inc (NBY)

0.7801 +0.08 (+10.64%) USD  |  NYAM  |  Nov 12, 16:00
0.7999 +0.02 (+2.54%) After-Hours: 20:00
More

NovaBay Pharmaceuticals Research and Development Expense (Quarterly): 0.009M for June 30, 2024

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2007. Upgrade now.
Date Value
June 30, 2024 0.009M
March 31, 2024 0.019M
December 31, 2023 0.004M
September 30, 2023 0.011M
June 30, 2023 0.022M
March 31, 2023 0.01M
December 31, 2022 0.066M
September 30, 2022 0.041M
June 30, 2022 0.04M
March 31, 2022 0.028M
December 31, 2021 0.008M
September 30, 2021 0.01M
June 30, 2021 0.021M
March 31, 2021 0.005M
December 31, 2020 0.036M
September 30, 2020 0.125M
June 30, 2020 0.115M
March 31, 2020 0.009M
December 31, 2019 0.018M
September 30, 2019 0.049M
June 30, 2019 0.032M
March 31, 2019 0.085M
December 31, 2018 0.107M
September 30, 2018 0.045M
June 30, 2018 0.061M
Date Value
March 31, 2018 0.046M
December 31, 2017 0.146M
September 30, 2017 0.132M
June 30, 2017 0.07M
March 31, 2017 0.062M
December 31, 2016 0.156M
September 30, 2016 0.004M
June 30, 2016 0.278M
March 31, 2016 0.933M
December 31, 2015 1.225M
September 30, 2015 1.563M
June 30, 2015 1.357M
March 31, 2015 1.583M
December 31, 2014 2.405M
September 30, 2014 2.312M
June 30, 2014 2.238M
March 31, 2014 2.528M
December 31, 2013 4.037M
September 30, 2013 2.513M
June 30, 2013 2.937M
March 31, 2013 2.925M
December 31, 2012 2.119M
September 30, 2012 2.514M
June 30, 2012 2.378M
March 31, 2012 2.264M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

0.004M
Minimum
Dec 2023
0.125M
Maximum
Sep 2020
0.0314M
Average
0.019M
Median
Mar 2024

Research and Development Expense (Quarterly) Benchmarks

Palatin Technologies Inc 4.672M
iBio Inc 1.14M
Theriva Biologics Inc 2.953M
Oragenics Inc 0.9068M
Nanoviricides Inc 1.182M